FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
Obere Zahlbacher Str. 63, Geb. 912, 55131 Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Forschungsprojekte
Ergebnisse pro Seite:
10
2016 - 2017
VIOLET (17613): Efficacy and safety of three different Eylea regimens in subjects with DME- PD Dr. KatrinLorenz
2016 - 2018
BI 1320.22DME: Safety and effect on central retinal thickness of BI 1026706 in patients with diabetic macular edema- Dr. KatharinaBell,
- PD Dr. KatrinLorenz
2016 - 2021
A Phase IIb/III prospective, randomized, double-blind, sham-controlled trail of 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD) in subjects with neurologic manifestations of Niemann-Pick Type C1 (NPC1) Disease- Univ.-Prof. Dr. Julia BeatriceHennermann,
- Univ.-Prof. Dr. JörgFaber,
- Prof. Dr. IreneKrämer
2016 - 2020
A Phase III open-label, multicenter trial of maintenance therapy with Avelumab* (MSB0010718C) versus continuation of first-line chemotherapy in subjects with unresectable, locally advanced or metastatic adenocarcinoma of the stomach or of the gastro-esophageal junction- Prof. Dr. MarkusMöhler
2016
Control of Anaplasma phagocytophilum by interaction of neutrophil granulocytes and T-cells- PD Dr. Friederikevon Loewenich